Novel mechanism for UVRAG in genome stability and tumor suppression
Novel mechanism for UVRAG in genome stability and tumor suppression
批准号:
10221855
负责人:
Chengyu Liang
金额:
$12.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-21 至 2021-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Due to the unacceptable toxicity and ineffectiveness of currently available cancer chemotherapy and radiation, the search for new molecular targets is in high gear. While initially identified as a promoter of the autophagy pathway, UVRAG (UV irradiation-resistance associated gene) has now emerged in our recent studies as a bona fide guardian of the genome. Specifically, we have discovered that this protein mediates the repair of damaged DNA by targeting DNA-PK and patrols centrosome stability by targeting CEP63 in a manner independent of its role in autophagy signaling. We propose that UVRAG is a novel regulator of chromosomal stability, supporting a direct causal role for UVRAG inactivation in cancer development. To the best of our knowledge, these studies represent the first description of an autophagy-related factor directly functioning in centrosome regulation and DNA repair to maintain genome integrity. Thus, the proposed research will expand on this knowledge to comprehensively assess the molecular mechanisms by which UVRAG interacts with DNA-PK to activate DNA repair upon double-strand breaks (DSBs) (Aim 1) and targets CEP63 to prevent centrosome amplification (Aim 2), thereby maintaining both structural and numeric chromosomal integrity of cells. Furthermore, to determine the in vivo contribution and specific roles of chromosomal instability and autophagy in UVRAG-associated tumor suppression (Aim 3), we will develop a drug-inducible transgenic murine model, which faithfully recapitulates an oncogenic lesion of UVRAG found in human cancers. These aims will be addressed using multidisciplinary innovative approaches that integrate state-of-the art genetic, biochemistry, quantitative live-cell imaging, and physiological assays in cells and in mice with targeted mutations in genes that are related to UVRAG and required for the regulation of genomic stability and autophagy. Results gained from this study will undoubtedly illuminate new views on UVRAG as an autophagic tumor suppressor and a protector of the genome, reveal functional interactions between UVRAG, autophagy, and genomic instability, and also hold promise for the development of novel therapeutics for cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New control of oncogene activation in T-cell leukemia
-
批准号:10609073
-
项目类别:
-
资助金额:$50.42万
-
财政年份:2022
-
负责人:Chengyu Liang
-
依托单位:
New control of oncogene activation in T-cell leukemia
-
批准号:10443113
-
项目类别:
-
资助金额:$54.19万
-
财政年份:2022
-
负责人:Chengyu Liang
-
依托单位:
Molecular Mechanism of UV Protection in Cutaneous Melanoma
-
批准号:10294255
-
项目类别:
-
资助金额:$62.23万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
-
批准号:10264124
-
项目类别:
-
资助金额:$57.74万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
Targeting the host NDP kinase to abrogate viral dissemination
-
批准号:10223818
-
项目类别:
-
资助金额:$13.63万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
Molecular Mechanism of UV Protection in Cutaneous Melanoma
-
批准号:10542439
-
项目类别:
-
资助金额:$62.23万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
-
批准号:10320079
-
项目类别:
-
资助金额:$56.58万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
-
批准号:10230378
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
Molecular Mechanism of UV Protection in Cutaneous Melanoma
-
批准号:10225017
-
项目类别:
-
资助金额:$43.97万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
Molecular Mechanism of UV Protection in Cutaneous Melanoma
-
批准号:10318542
-
项目类别:
-
资助金额:$62.23万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
-
批准号:10517499
-
项目类别:
-
资助金额:$57.04万
-
财政年份:2020
-
负责人:Chengyu Liang
-
依托单位:
A cancer-derived truncating mutation in disease penetrance and progression of MSI CRC
-
批准号:9885369
-
项目类别:
-
资助金额:$19.05万
-
财政年份:2019
-
负责人:Chengyu Liang
-
依托单位:
A Novel Modulator of Notch in Acute Lymphoblastic Leukemia
-
批准号:8309060
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2011
-
负责人:Chengyu Liang
-
依托单位:
A Novel Modulator of Notch in Acute Lymphoblastic Leukemia
-
批准号:8177140
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2011
-
负责人:Chengyu Liang
-
依托单位:
Novel mechanism for UVRAG in genome stability and tumor suppression
-
批准号:8979682
-
项目类别:
-
资助金额:$35.27万
-
财政年份:2009
-
负责人:Chengyu Liang
-
依托单位:
Immune Evasion of Autophagy in Gamma-Herpesviruses infection
-
批准号:7871367
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2009
-
负责人:Chengyu Liang
-
依托单位:
Role of UVRAG-mediated Autophagy in Tumor Suppression
-
批准号:8115770
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2009
-
负责人:Chengyu Liang
-
依托单位:
Role of UVRAG-mediated Autophagy in Tumor Suppression
-
批准号:8509618
-
项目类别:
-
资助金额:$27.59万
-
财政年份:2009
-
负责人:Chengyu Liang
-
依托单位:
Immune Evasion of Autophagy in Gamma-Herpesviruses infection
-
批准号:7708651
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2009
-
负责人:Chengyu Liang
-
依托单位:
Autophagy-mediated defense against inflammation and cancer
-
批准号:10296149
-
项目类别:
-
资助金额:$41.58万
-
财政年份:2009
-
负责人:Chengyu Liang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位: